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Abstract: The relevance of dietary fatty acids (FA) for blood lipids should be assessed in the context
of substituting nutrients. Such evidence is lacking for adolescents. This study describes prospective
associations of dietary FA with changes in serum lipids during adolescence, and considers the
theoretical isocaloric replacements of saturated FA (SFA) with other FA or carbohydrates (CHO).
Children from the GINIplus and LISAplus birth cohorts, with data on FA intakes (at age 10 years) and
serum lipids (at age 10 and 15 years), were included (n = 1398). Associations of SFA, monounsaturated
FA (MUFA), n-3 polyunsaturated FA (n-3 PUFA) and n-6 PUFA, with changes in low-density
lipoprotein (LDL), high-density lipoprotein (HDL), triglycerides (TAG), and total cholesterol to
HDL ratio (TOTAL:HDL), were assessed by linear regression. Substitution models assessed isocaloric
replacements of SFA with MUFA, n-3 PUFA, n-6 PUFA or CHO. Higher SFA intakes were associated
with decreasing TAG. No associations were observed for fatty acid intakes with LDL, HDL or
TOTAL:HDL. In females, replacing SFA with CHO was associated with increasing LDL, TAG and
TOTAL:HDL. Our findings confirm observations in adults, although sex-specific determinants seem
relevant in our adolescent population. Overlooking the nutrient context when limiting SFA intakes
might have detrimental consequences appreciable as early as adolescence.
Keywords: fatty acids; lipids; isocaloric substitution; diet; carbohydrates; adolescence; epidemiology
1. Introduction
Since the first appearance of evidence suggesting a detrimental role of saturated fatty acids
(SFA) in the development of coronary heart disease [1,2], the advice to reduce SFA consumption has
become a major component of health-promoting strategies [3]. Nevertheless, inconsistent findings
among emerging studies have led scientists to question the independent association of SFA with the
development of cardiovascular disease (CVD) [4–6]. It has become clear that evidence supporting
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a reduction of SFA intake must be interpreted in the context of the specific nutrients consumed in
its place [7,8]. In 2008, the FAO and the WHO stated convincing evidence for an improved lipoprotein
profile in adults when replacing SFA with polyunsaturated fatty acids (PUFA) and, to a lesser extent, with
monounsaturated fatty acids (MUFA). On the other hand, replacing SFA with carbohydrates (CHO) was
reported to reduce low-density lipoprotein (LDL) but also high-density lipoprotein (HDL) levels [9].
It is currently well established that CVD risk factors progress from childhood and adolescence
into adulthood [10]. Results from numerous longitudinal cohort studies have indicated strong tracking
of serum lipids from childhood to adulthood [11–13]. Considering the implications this can have for
later disease development, improving our understanding of the role of dietary fatty acid intakes in
children is of major importance for the early implementation of dietary advice. The period concerning
pubertal development is of interest due to the rapid growth and development as well as behavioral
changes occurring at this stage [14,15]. However, despite the growing evidence in adults [16–18],
the amount of reliable and comparable data on dietary fatty acid intakes in children and adolescents
is scarce [19]. Studies observing the associations of total [20–22] and saturated fat [23,24] with blood
lipid concentrations have reported mixed results. In particular, longitudinal studies on the theoretical
implication of different replacements of SFA on lipid profiles in children and adolescents are lacking.
A 2002 study using repeated measures at ages 8 and 11 years, suggested associations with serum lipids
similar to those observed in adults when replacing SFA with MUFA or PUFA [25]. Further studies are
required to learn whether such associations persist during the period of pubertal development.
The current study therefore aims to describe the prospective associations of fatty acid intakes
during childhood with changes in serum lipid concentrations during adolescence. Furthermore, we are
interested in observing how associations with SFA may depend on the choice of substituting nutrient.
We therefore consider changes in blood lipids following the theoretical reduction of SFA in the context
of different isocaloric replacements with other fatty acids or with carbohydrates.
2. Materials and Methods
2.1. Participants
The present study used data from the 10- and 15-year follow-up assessments of the ongoing
GINIplus (German Infant Nutritional Intervention plus environmental and genetic influences on
allergy development) and LISAplus (Influence of Lifestyle-Related Factors on the Immune System and
the Development of Allergies in Childhood plus the Influence of Traffic Emissions and Genetics)
birth cohort studies. Healthy full-term newborns were recruited from obstetric clinics in four
German cities. Information was collected using identical questionnaires and at physical examinations.
The study designs, recruitment and exclusion criteria have been described previously [26,27]. For both
studies, approval by the local ethics committees (Bavarian General Medical Council, University of
Leipzig, Medical Council of North-Rhine-Westphalia) and written consent from participants’ families
were obtained.
2.2. Dietary Intake
Dietary intake data were collected at the 10-year follow-up assessment, using a self-administered
food frequency questionnaire (FFQ) designed to assess food and nutrient intake over the past year
in school-aged children, and validated to estimate energy, fatty acid and antioxidant intake [28].
In brief, subjects were asked to report estimated frequency and portion size of intakes of 80 food
items. A quality control procedure was applied based on recommendations by Willett et al. for data
cleaning in nutritional epidemiology [29,30]. Total daily energy intake and the intakes of SFA, MUFA,
n-6 and n-3 PUFA, protein, carbohydrate and alcohol were calculated (in kcal/day) based on the
German Food Code and Nutrient Database (BLS) version II.3.1 [31]. Each nutrient was expressed as its
percentage contribution towards total daily energy intake (%EI), calculated as the ratio of energy from
each nutrient to total daily energy intake, multiplied by 100.
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2.3. Blood Lipids
Blood samples were obtained during the 10- and 15-year follow-up physical examinations.
The concentrations (mmol/L) of total cholesterol, LDL, HDL, and triglycerides (TAG) were measured in
serum using homogenous enzymatic colorimetric methods on a Modular Analytics System from Roche
Diagnostics GmbH Mannheim according to the manufactures instructions. External controls were
used in accordance with the guidelines of the German Society of Clinical Chemistry and Laboratory
Medicine. The ratio of total to HDL cholesterol (TOTAL:HDL) was calculated by dividing total
cholesterol by HDL.
2.4. Statistical Analyses
Participants with complete data on FA intakes at age 10 years, serum lipids at age 10 and 15 years,
and all adjustment variables were included in the study (Figure 1). To test for differences due to
attrition bias, we compared characteristics of participants lost to follow-up (data only available for
exposure and outcome at 10 years) to those included in the present study analyses, who adhered at
follow-up (data available for exposure at 10 years and outcome at 10 years and 15 years). Categorical
variables, presented as percentages, were tested by Fisher’s exact test (binary variables) or Pearson’s
Chi-squared test (variables with more than 2 levels). Continuous variables, presented as means
(standard deviation), were tested by Student’s t-test.
Statistical analyses were carried out in the total population and stratified by sex. Subject
characteristics at ages 10 and 15 years were described by medians (25th percentile; 75th percentile) or
counts (%). Differences from 10 to 15 years were tested using paired Wilcoxon signed rank test for
continuous variables and McNemar’s χ2-test for categorical variables. Differences in characteristics
between males and females at each assessment were tested using Wilcoxon signed rank test for
continuous variables and χ2-test for categorical variables (Fisher’s exact test for binary variables).
Changes (∆) in lipid concentrations and in TOTAL:HDL ratio were calculated by subtracting each
measurement at the 10-year follow-up from its respective measurement at the 15-year follow-up.
Using linear regression, two modelling approaches were applied. First, single nutrient models
were fit to observe the changes in blood lipids when increasing habitual intakes of a single nutrient at
a constant energy intake. Intakes of different fatty acids assessed at age 10 years were considered as
the exposures of interest. Separate regression models were run for each exposure (SFA, MUFA, n-3
PUFA or n-6 PUFA) with the different blood lipid parameters (∆LDL, ∆HDL, ∆TAG, ∆TOTAL:HDL).
Through this prospective approach, we aim to avoid any misleading findings emerging from the
possible bidirectional relationship between fatty acid intakes and blood lipids assessed at a single
time-point only. Second, substitution models were fit to observe the effect of replacing SFA with other
fatty acids (MUFA, n-6 PUFA and n-3 PUFA) or with CHO, on the different blood lipid parameters
(∆LDL, ∆HDL, ∆TAG, ∆TOTAL:HDL). These models included the exposure nutrient of interest as
well as all other energy-bearing nutrients except SFA (the nutrient being “replaced”). In this way,
energy intakes of protein, carbohydrate, alcohol and other fats are held constant; and by additionally
including total energy intake in the model it is possible to interpret the resulting coefficients for
each nutrient as its theoretical substitution for an equal amount of energy (%EI) from saturated fat,
being the only energy-bearing nutrient not accounted for in the model. All models were adjusted
for potential covariates in two steps. First, we adjusted for basic covariates (MBASIC): study (GINI
observation arm; GINI intervention arm; LISA), recruitment region (Munich; Wesel; Bad Honnef;
Leipzig), sex (male; female)—not in sex-stratified models—exact age at 10-year blood sampling
(years), fasting status at blood sampling (not fasted (46%); fasted at one assessment (45%); fasted at
both assessments (9%)), BMI (kg/m2) at age 10 years, screen-time (daily hours spent on activities
in front of a screen: ≤2 h = low; >2 h = high) at age 10 years, total energy intake (kcal/day) at age
10 years, and lipid concentration (mmol/L) at age 10 years. In a second step, models were further
adjusted for other potential confounders (MADJ): parental education level (highest level achieved
by mother or father: ≤10th grade = low/medium; >10th grade = high) and pubertal onset at age
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10 years (oestrogen ≥ 18.5 pmol/L or testosterone ≥ 0.1 nmol/L = yes; oestrogen < 18.5 pmol/L
or testosterone < 0.1 mmol/L = no). Given the high intercorrelation typically present amongst
dietary components [32], we calculated correlation coefficients between pairs of nutrient variables,
using Pearson’s product-moment correlation coefficient. A high negative correlation was observed
between MUFA and CHO. By linearly regressing MUFA onto CHO and vice-versa, we computed
residuals (MUFARESID and CHORESID), which were uncorrelated with each other [33]. In order to
avoid multicollinearity, these were included in the models as a stand-in for the original variable
only when acting as a covariate (i.e., when assessing the effect of replacing SFA with CHO, CHO
was included in its original form as the main predictor variable, and MUFARESID was included in
place of MUFA, along with all other covariates, and vice versa). Results from the linear regression
analyses are presented as regression coefficients (β) per interquartile range (IQR) increase in the
relevant exposure variable, along with their 95% confidence interval (95% CI). A two-sided α-level
of 5% was considered significant for the total population analyses. For the sex-stratified analysis we
corrected for multiple testing using Bonferroni correction: the α-level was divided by 2 (2.5%) as the
dataset was analyzed by sub-groups of two levels (male/female). Statistical analyses were conducted
using R (www.r-project.org), version 3.3.0 [34].
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Figure  1. Study participants Dietary  intake:  intakes of  fatty acids  (saturated, monounsaturated, n‐3 
polyunsaturated, n‐6 polyunsaturated), carbohydrate, protein, and alcohol obtained from FFQ; Blood 
lipids:  low‐density  lipoprotein  (LDL),  high‐density  lipoprotein  (HDL),  triglycerides;  adjustment 
variables: study, region, age, fasting status, BMI, screen‐time, total energy intake, lipid concentration at 
age  10  years,  parental  education  and  pubertal  onset;  Illness  affecting  diet:  e.g.,  diabetes,  anorexia, 
coeliac disease, cancer, or medical dietary indications (e.g., gluten‐free, lactose‐free diets). 
Figure 1. Study participa t ry intake: intakes of fatty acids (s urated, mono nsaturated,
n-3 polyunsaturated, n-6 polyunsaturated), carbohydrate, protein, and alcohol obtained from FFQ;
Blood lipids: low-density lipoprotein (LDL), high-density lipoprotein (HDL), triglycerides; adjustment
variables: study, region, age, fasting status, B I, screen-time, total energy intake, lipid concentration
at age 10 years, parental education and pubertal onset; Illness affecting diet: e.g., diabetes, anorexia,
coeliac disease, cancer, or medical dietary indications (e.g., gluten-free, lactose-free diets).
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3. Results
3.1. Study Population
The present analyses comprised of 1398 participants (681 females and 717 males). The derivation
of the study population is presented in Figure 1. Subjects providing complete dietary intake data at
age 10 years, measures of serum lipids at both 10 and 15 years, as well as information on all adjustment
variables, were included (n = 1473). Differences in descriptive characteristics between participants
included in the analyses and participants lost to follow-up are presented in the Table S1). Participants
were excluded if they reported an illness affecting diet (e.g., diabetes, anorexia, coeliac disease, cancer)
or medical dietary indications, such as gluten-free or lactose-free diets (n = 64). Clear outliers in blood
lipid concentrations (n = 10), or adjustment variables (n = 1) were visually identified using descriptive
plots and excluded from the analyses. Basic characteristics of the study population at age 10 and
15 years are described in Table 1. Both sexes had higher levels of LDL and HDL and lower levels
of TAG and TOTAL:HDL at age 15 years compared to 10 years. Significant differences over time
were observed for BMI, fasting status at blood sampling, screen-time and total daily energy intake,
with higher values at age 15 years in both sexes (except energy intake, which decreased in females).
Males reported higher screen-time and daily energy intake than females at both time-points, as well as
higher fat and protein intakes at age 15. On the other hand, females at age 15 years reported higher
carbohydrate intakes. Overall, most participants were from Munich (57.7%) with a high parental
education (71.3%). Notably, more females than males had reached pubertal onset at the age of 10 years
(74.4% females vs. 24.1% males).
3.2. Single Nutrient Models
The prospective associations of dietary fatty acid intakes (in %EI) at age 10 years with changes in
serum lipid concentrations from age 10 to age 15 years are described in Table 2. Values are presented
for basic (MBASIC) and fully adjusted models (MADJ). The resulting β-coefficients indicate the changes
in blood lipid concentrations (mmol/L) per IQR increase in the %EI of a given fatty acid, while
maintaining total energy intake constant. A significant inverse association was observed between
the intake of SFA (IQR increase in %EI) at age 10 years and the change in TAG concentrations from
age 10 to age 15 years (MADJ: β = −0.038 (95% CI = −0.075; −0.001), p-value = 0.042). A similar
association was observed in females only, which was borderline statistically significant when corrected
for multiple testing (MADJ: −0.053 (−0.100; −0.007), p-value = 0.025). No associations were observed
for any of the fatty acid exposures with the other assessed blood lipid parameters.
3.3. Substitution Models
Table 3 shows the prospective associations of different dietary fatty acid intakes and CHO at age
10 years with changes in serum lipid concentrations from age 10 to age 15 years, when considering their
theoretical substitution for SFA. Values are presented for basic (MBASIC) and fully adjusted models
(MADJ). Coefficients (β) obtained from these models represent an isocaloric substitution, i.e., the change
in blood lipid concentrations when theoretically replacing the intake of SFA with another (specific)
fatty acid or CHO, while maintaining total energy intake constant. A direct association was observed
in the basic model for the substitution of CHO (IQR increase in %EI) for SFA with ∆LDL (MBASIC:
0.063 (0.000; 0.127), p-value = 0.05). Sex-stratified analyses indicated significant associations in females
only, after correction for multiple testing: direct associations were observed for the substitution of CHO
(IQR increase in %EI) for SFA with ∆LDL (MADJ: 0.125 (0.021; 0.229), p-value = 0.019), ∆TAG (MADJ:
0.098 (0.020; 0.176), p-value = 0.014), and ∆TOTAL:HDL (MADJ: 0.115 (0.015; 0.215), p-value = 0.024).
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Table 1. Basic characteristics of the study population.
Variables
Total (N = 1398) Females (N = 681) Males (N = 717)
10 Years 15 Years p-Value a 10 Years 15 Years p-Value a 10 Years 15 Years p-Value a
Blood lipids
LDL (mmol/L) 2.1 (1.7; 2.5) 2.3 (1.9; 2.7) <0.01 2.1 (1.8; 2.5) † 2.4 (2.0; 2.9) † <0.01 2.0 (1.7; 2.5) 2.2 (1.8; 2.6) <0.01
HDL (mmol/L) 1.2 (1.1; 1.4) 1.5 (1.2; 1.7) <0.01 1.2 (1.1; 1.4) 1.6 (1.4; 1.8) † <0.01 1.3 (1.1; 1.5) § 1.4 (1.2; 1.6) <0.01
TAG (mmol/L) 1.2 (0.9; 1.6) 1.0 (0.8; 1.4) <0.01 1.2 (0.9; 1.6) 1.0 (0.8; 1.3) <0.01 1.1 (0.8; 1.6) 1.0 (0.7; 1.4) <0.01
TOTAL:HDL 3.8 (3.2; 4.5) 2.9 (2.5; 3.4) <0.01 3.9 (3.4; 4.6) † 2.9 (2.5; 3.4) <0.01 3.6 (3.2; 4.4) 3.0 (2.5; 3.5) § <0.01
Fatty acids
SFA (%EI) 12.6 (10.9; 14.7) 12.7 (10.8; 14.7) 0.621 12.5 (10.7; 14.7) 12.6 (10.6; 14.6) 0.190 12.8 (11.1; 14.8) 12.9 (10.9; 14.9) 0.512
MUFA (%EI) 10.7 (9.3; 12.3) 10.8 (9.4; 12.3) 0.133 10.7 (9.2; 12.1) 10.5 (9.1; 12.2) 0.608 10.7 (9.5; 12.4) 11.2 (9.6; 12.6) § <0.01
n-3 PUFA (%EI) 0.54 (0.49; 0.62) 0.56 (0.49; 0.65) <0.01 0.55 (0.49; 0.63) 0.57 (0.49; 0.64) 0.009 0.54 (0.48; 0.62) 0.56 (0.48; 0.65) <0.01
n-6 PUFA (%EI) 3.7 (3.2; 4.3) 3.9 (3.3; 4.6) <0.01 3.7 (3.2; 4.3) 3.9 (3.3; 4.7) 0.002 3.7 (3.2; 4.3) 3.9 (3.3; 4.6) <0.01
Covariates
Age (years) 10.2 (10.1; 10.3) 15.1 (15.0; 15.3) <0.01 10.2 (10.1; 10.3) 15.1 (15; 15.3) <0.01 10.2 (10.1; 10.3) 15.1 (15; 15.3) <0.01
BMI (kg/m2) 16.7 (15.6; 18.4) 20.2 (18.7; 22.2) <0.01 16.8 (15.6; 18.5) 20.4 (18.9; 22.3) <0.01 16.7 (15.7; 18.4) 20 (18.6; 22.1) <0.01
Fasting (yes) 237 (17.0) 649 (46.4) <0.01 b 121 (17.8) 309 (45.2) <0.01 b 116 (16.2) 341 (47.6) <0.01 b
Screen-time (high) 134 (9.6) 763 (55.3) <0.01 b 48 (7.0) 322 (47.8) <0.01 b 86 (12.0) § 442 (62.5) § <0.01 b
Energy intake (kcal) 1933 (1591; 2292) 2011 (1584; 2532) <0.01 1798 (1486; 2124) 1734 (1360; 2115) 0.016 2061 (1705; 2447) § 2361 (1884; 2866) § <0.01
Fat (%EI) 30.1 (26.7; 34.2) 30.5 (27.1; 34.8) 0.128 29.9 (26.1; 33.9) 30.0 (26.5; 34.2) 0.982 30.2 (27.3; 34.4) 30.9 (27.6; 35.3) § 0.029
Carbohydrate (%EI) 54.1 (49.6; 58.0) 53.2 (48.6; 57.7) 0.004 54.3 (49.7; 58.4) 54.1 (49.1; 58.4) † 0.696 53.7 (49.6; 57.5) 52.4 (47.7; 56.7) <0.01
Protein (%EI) 14.5 (12.9; 16.0) 14.8 (13.1; 16.6) <0.01 14.4 (12.8; 16.1) 14.5 (12.7; 16.3) 0.452 14.5 (13.1; 16.0) 15.1 (13.4; 16.8) § <0.01
Study
GINI observation 452 (32.3) 221 (32.5) 231 (32.2)
GINI intervention 437 (31.3) 224 (32.9) 213 (29.7)
LISA 509 (36.4) 236 (34.7) 273 (38.1)
Region
Munich 807 (57.7) 389 (57.1) 418 (58.3)
Leipzig 123 (8.8) 60 (8.8) 63 (8.8)
Bad Honnef 65 (4.6) 29 (4.3) 36 (5.0)
Wesel 403 (28.8) 203 (29.8) 200 (27.9)
Parental education (High) 997 (71.3) 497 (73.0) 500 (69.7)
Pubertal onset (Yes) 680 (48.6) 507 (74.4) † 173 (24.1)
Values are medians (25th percentile; 75th percentile) or counts (%); LDL = low-density lipoprotein; HDL = high-density lipoprotein; TAG = triglycerides; SFA = saturated fatty acids;
TOTAL:HDL = total cholesterol to HDL ratio; MUFA = monounsaturated fatty acids; PUFA = polyunsaturated fatty acids; a tested by paired Wilcoxon signed rank test; b tested by
McNemar’s chi-squared test; † value is significantly greater in females than in males at the respective time-point (p-value < 0.05, tested by Wilcoxon signed rank test or Fisher’s exact test);
§ value is significantly greater in males than in females at the respective time-point (p-value < 0.05, tested by Wilcoxon signed rank test or Fisher’s exact test).
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Table 2. Single nutrient model: prospective associations of dietary fatty acid intakes at age 10 years (per IQR increase in %EI) with changes in blood lipid concentrations
(mmol/L) from age 10 to 15 years.
Fatty Acids
∆LDL ∆HDL ∆TAG ∆TOTAL:HDL
β 95% CI p-Value β 95% CI p-Value β 95% CI p-Value β 95% CI p-Value
TOTAL
SFA MBASIC −0.038 −0.077; 0.001 0.057 0.005 −0.017; 0.027 0.653 −0.038 −0.075; −0.001 0.042 −0.030 −0.075; 0.015 0.196
MADJ −0.036 −0.075; 0.003 0.068 0.005 −0.017; 0.027 0.638 −0.038 −0.075; −0.001 0.042 −0.029 −0.074; 0.016 0.209
MUFA MBASIC −0.012 −0.048; 0.024 0.519 0.011 −0.010; 0.031 0.306 −0.012 −0.046; 0.023 0.507 −0.017 −0.059; 0.025 0.428
MADJ −0.011 −0.048; 0.025 0.534 0.011 −0.009; 0.031 0.297 −0.012 −0.046; 0.023 0.503 −0.017 −0.059; 0.025 0.430
n-3 PUFA MBASIC −0.027 −0.058; 0.003 0.075 0.005 −0.012; 0.022 0.590 0.001 −0.028; 0.030 0.953 −0.017 −0.052; 0.018 0.342
MADJ −0.027 −0.057; 0.003 0.082 0.005 −0.012; 0.022 0.540 0.000 −0.028; 0.029 0.981 −0.017 −0.053; 0.018 0.332
n-6 PUFA MBASIC −0.003 −0.034; 0.028 0.866 0.015 −0.002; 0.032 0.089 0.009 −0.020; 0.039 0.525 −0.012 −0.048; 0.024 0.504
MADJ −0.003 −0.034; 0.028 0.849 0.016 −0.002; 0.033 0.074 0.009 −0.021; 0.038 0.559 −0.013 −0.049; 0.023 0.465
FEMALES
SFA MBASIC −0.048 −0.110; 0.014 0.131 0.012 −0.022; 0.045 0.491 −0.053 −0.100; −0.006 0.026 −0.057 −0.116; 0.002 0.060
MADJ −0.047 −0.110; 0.015 0.139 0.012 −0.022; 0.045 0.484 −0.053 −0.100; −0.007 0.025 −0.057 −0.116; 0.002 0.060
MUFA MBASIC −0.004 −0.061; 0.053 0.888 0.020 −0.011; 0.050 0.211 −0.017 −0.060; 0.026 0.430 −0.026 −0.081; 0.028 0.342
MADJ −0.005 −0.062; 0.053 0.876 0.020 −0.011; 0.050 0.209 −0.018 −0.061; 0.025 0.420 −0.027 −0.081; 0.028 0.336
n-3 PUFA MBASIC −0.030 −0.078; 0.018 0.219 0.011 −0.015; 0.037 0.406 0.000 −0.036; 0.036 0.990 −0.032 −0.077; 0.014 0.173
MADJ −0.030 −0.079; 0.018 0.214 0.011 −0.015; 0.037 0.403 0.000 −0.036; 0.036 0.998 −0.032 −0.078; 0.014 0.169
n-6 PUFA MBASIC −0.020 −0.068; 0.028 0.409 0.019 −0.007; 0.044 0.148 0.016 −0.020; 0.052 0.390 −0.026 −0.071; 0.020 0.269
MADJ −0.021 −0.069; 0.027 0.397 0.020 −0.006; 0.046 0.124 0.014 −0.022; 0.050 0.446 −0.028 −0.074; 0.018 0.231
MALES
SFA MBASIC −0.029 −0.078; 0.019 0.237 −0.002 −0.031; 0.026 0.868 −0.016 −0.072; 0.04 0.577 0.002 −0.066; 0.070 0.962
MADJ −0.026 −0.075; 0.022 0.282 −0.003 −0.031; 0.026 0.863 −0.015 −0.072; 0.041 0.591 0.003 −0.065; 0.071 0.929
MUFA MBASIC −0.021 −0.066; 0.025 0.372 0.000 −0.027; 0.027 0.975 −0.002 −0.055; 0.051 0.952 −0.001 −0.065; 0.063 0.972
MADJ −0.019 −0.065; 0.026 0.400 0.001 −0.026; 0.027 0.964 −0.002 −0.056; 0.051 0.927 −0.001 −0.065; 0.063 0.968
n-3 PUFA MBASIC −0.026 −0.064; 0.012 0.181 −0.003 −0.025; 0.02 0.818 0.005 −0.040; 0.049 0.826 0.001 −0.053; 0.055 0.971
MADJ −0.025 −0.063; 0.013 0.199 −0.001 −0.023; 0.022 0.952 0.003 −0.042; 0.048 0.891 0.000 −0.054; 0.054 0.992
n-6 PUFA MBASIC 0.011 −0.029; 0.051 0.583 0.010 −0.013; 0.034 0.392 0.001 −0.045; 0.048 0.953 0.000 −0.056; 0.056 0.991
MADJ 0.013 −0.027; 0.052 0.534 0.012 −0.011; 0.036 0.299 −0.001 −0.047; 0.046 0.975 −0.001 −0.057; 0.055 0.971
IQR = interquartile range; %EI = % of total energy intake; MBASIC = single nutrient model adjusted for study, region, sex (not in sex-stratified models), exact age at blood sampling, BMI at
10 years, total daily energy intake at 10 years, screen-time at 10 years, fasting status at blood sampling, and lipid concentration at 10 years; MADJ = single nutrient model further adjusted
for pubertal onset and parental education; ∆ = change from age 10 to 15 years; Significant associations marked in bold (p-value < 0.05 for total population analyses, p-value < 0.025 for
sex-stratified analyses—Bonferroni correction for multiple testing: 0.05/2).
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Table 3. Substitution model: prospective associations of fatty acids and carbohydrates (CHO) (when replacing SFA) at age 10 years (per IQR increase in %EI), with
changes in blood lipid concentrations (mmol/L) from age 10 to 15 years.
Substituting
Nutrient
∆LDL ∆HDL ∆TAG ∆TOTAL:HDL
β 95% CI p-Value β 95% CI p-Value β 95% CI p-Value β 95% CI p-Value
TOTAL
MUFA MBASIC −0.037 −0.085; 0.011 0.134 0.002 −0.025; 0.029 0.897 −0.041 −0.087; 0.005 0.077 −0.027 −0.083; 0.029 0.346
MADJ −0.034 −0.082; 0.014 0.163 0.002 −0.025; 0.029 0.894 −0.041 −0.086; 0.005 0.081 −0.025 −0.082; 0.031 0.378
n-3 PUFA MBASIC −0.027 −0.064; 0.011 0.164 −0.003 −0.024; 0.018 0.752 0.002 −0.033; 0.037 0.913 −0.008 −0.052; 0.036 0.715
MADJ −0.026 −0.063; 0.012 0.179 −0.003 −0.024; 0.018 0.775 0.002 −0.034; 0.037 0.916 −0.008 −0.052; 0.036 0.723
n-6 PUFA MBASIC 0.018 −0.019; 0.056 0.341 0.016 −0.005; 0.037 0.143 0.019 −0.017; 0.055 0.303 −0.001 −0.045; 0.043 0.978
MADJ 0.017 −0.021; 0.054 0.384 0.016 −0.005; 0.038 0.129 0.018 −0.018; 0.054 0.324 −0.002 −0.047; 0.042 0.916
CHO MBASIC 0.063 0.000; 0.127 0.050 −0.001 −0.036; 0.035 0.970 0.057 −0.003; 0.117 0.061 0.043 −0.031; 0.117 0.257
MADJ 0.060 −0.004; 0.123 0.064 −0.001 −0.037; 0.034 0.947 0.057 −0.003; 0.117 0.063 0.041 −0.033; 0.115 0.278
FEMALES
MUFA MBASIC −0.053 −0.130; 0.024 0.175 0.005 −0.037; 0.046 0.825 −0.065 −0.122; −0.007 0.029 −0.054 −0.127; 0.020 0.153
MADJ −0.052 −0.129; 0.025 0.188 0.005 −0.037; 0.046 0.824 −0.064 −0.122; −0.007 0.029 −0.053 −0.127; 0.020 0.154
n-3 PUFA MBASIC −0.020 −0.080; 0.039 0.502 −0.004 −0.036; 0.028 0.822 0.002 −0.043; 0.047 0.928 −0.003 −0.060; 0.053 0.907
MADJ −0.020 −0.079; 0.039 0.510 −0.004 −0.036; 0.028 0.788 0.003 −0.042; 0.048 0.895 −0.002 −0.059; 0.055 0.942
n-6 PUFA MBASIC −0.004 −0.062; 0.054 0.896 0.015 −0.016; 0.046 0.341 0.034 −0.009; 0.078 0.125 −0.005 −0.060; 0.050 0.856
MADJ −0.005 −0.063; 0.053 0.868 0.017 −0.014; 0.048 0.292 0.032 −0.012; 0.075 0.155 −0.008 −0.064; 0.047 0.774
CHO MBASIC 0.127 0.023; 0.231 0.017 −0.003 −0.059; 0.053 0.916 0.097 0.019; 0.175 0.015 0.114 0.014; 0.213 0.025
MADJ 0.125 0.021; 0.229 0.019 −0.004 −0.060; 0.052 0.891 0.098 0.020; 0.176 0.014 0.115 0.015; 0.215 0.024
MALES
MUFA MBASIC −0.027 −0.088; 0.033 0.373 −0.001 −0.036; 0.035 0.976 −0.015 −0.085; 0.055 0.668 −0.006 −0.091; 0.079 0.898
MADJ −0.024 −0.084; 0.036 0.435 −0.001 −0.037; 0.035 0.948 −0.015 −0.085; 0.056 0.683 −0.004 −0.089; 0.082 0.934
n-3 PUFA MBASIC −0.043 −0.091; 0.005 0.079 −0.008 −0.037; 0.020 0.570 0.006 −0.050; 0.062 0.833 −0.009 −0.076; 0.059 0.796
MADJ −0.043 −0.090; 0.005 0.081 −0.007 −0.035; 0.021 0.630 0.005 −0.050; 0.061 0.851 −0.009 −0.077; 0.058 0.788
n-6 PUFA MBASIC 0.041 −0.009; 0.090 0.106 0.017 −0.012; 0.046 0.256 −0.004 −0.061; 0.054 0.898 0.001 −0.069; 0.071 0.985
MADJ 0.041 −0.008; 0.090 0.103 0.018 −0.011; 0.048 0.224 −0.004 −0.062; 0.053 0.880 0.000 −0.070; 0.070 0.995
CHO MBASIC 0.017 −0.059; 0.093 0.658 −0.001 −0.046; 0.044 0.961 0.021 −0.068; 0.109 0.647 −0.008 −0.115; 0.099 0.884
MADJ 0.012 −0.064; 0.088 0.755 0.000 −0.045; 0.045 0.991 0.020 −0.069; 0.108 0.663 −0.011 −0.118; 0.096 0.842
IQR = interquartile range; %EI = % of total energy intake; MBASIC = substitution model adjusted for study, region, sex (not in sex-stratified models), exact age at blood sampling, BMI
at 10 years, total daily energy intake at 10 years, screen-time at 10 years, fasting status at blood sampling, lipid concentration at 10 years, and all energy-bearing nutrients except SFA;
MADJ = substitution model further adjusted for pubertal onset and parental education; ∆ = change from age 10 to 15 years; Significant associations marked in bold (p-value < 0.05 for total
population analyses, p-value < 0.025 for sex-stratified analyses—Bonferroni correction for multiple testing: 0.05/2).
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4. Discussion
The present study used data from two large German birth cohorts to assess the prospective associations
of fatty acid intakes with changes in blood lipid concentrations during adolescence. We found that
higher intakes of SFA at age 10 years were associated with decreasing TAG between ages 10 and
15 years. Furthermore, we observed that the consumption of CHO at the expense of SFA in females
was associated with increasing LDL, TAG and TOTAL:HDL.
4.1. Single Nutrient Model
Our findings regarding the prospective association of SFA intakes with reduced TAG concentrations
are in line with existing literature in adults [35]. The observed relationship might be considered
somewhat counterintuitive, given the suggestions for a possible detrimental role of SFA in the
development of coronary heart disease [1,2]. Conflicting evidence has been reported in younger
populations, although existing studies are scarce and heterogeneous in terms of design, statistical
methods and outcome measurements. A study in children aged 6 to 12 years, reported a positive
association between SFA and total cholesterol concentrations [36], whereas an inverse association
was observed in a study in 15-year-olds [37]. Other studies have reported no association between
dietary fatty acids and blood lipids in pre-pubertal and pubertal children [24,38]. The often-observed
association of SFA consumption with increased LDL in adults [35] was not present in our adolescent
population. In fact, we observed a negative relationship in our total study sample, although the
association did not reach statistical significance (p-value = 0.068). Although the evidence for an
association of SFA with LDL has been widely accepted, recent studies in adults have emerged, reporting
no association between SFA and CVD risk [4]. Nonetheless, the present results should be interpreted
in the context of possible correlations among different nutrients. In our dietary data, SFA was highly
positively correlated with MUFA (r = 0.77), and also presented strong negative correlations with CHO
(r = −0.81), which limits the ability to disentangle the individual effects of SFA [32]. In light of this and
the inverse association observed between SFA and TAG levels in the current study, we speculate that
increasing the intake of SFA might have led to decreasing TAG levels indirectly through a reduction
in CHO intake. Indeed, CHO, in particular simple sugars, have been shown to have a detrimental
impact on blood lipids through raising TAG levels [39]. This has been suggested to result mainly from
increased hepatic secretion of very-low-density lipoprotein (VLDL) as well as impaired plasma TAG
clearance, possibly induced by reduced insulin sensitivity [40].
4.2. Substitution Model
Results from our substitution analyses showed that replacing SFA with CHO was associated with
increasing LDL, TAG and TOTAL:HDL in females. Our findings are in line with studies in adults
which report a detrimental effect on blood lipids when substituting CHO for SFA [41]. However,
the specific effects on blood lipid parameters differed from those observed in adults, who typically
present lower LDL levels [9,42,43] occurring in parallel with decreasing HDL levels, and having
no effect on the TOTAL:HDL ratio [44]. An increase in LDL is, however, plausible if we consider
results from randomized controlled trials which have reported positive linear associations of CHO
with small-dense LDL [45]. Other studies have shown positive relationships between dietary sugars
with plasma LDL and TAG [46]. In agreement with this and other studies [8,9,41,44] females in
our study population also presented positive associations between CHO and TAG. This relationship
can be attributed to the increased secretion of VLDL and impaired plasma TAG clearance described
above. The greater number of VLDL particles in the blood could also have led to the increase in
the LDL production rate [40], which was further reflected by the lower TOTAL:HDL ratio observed
amongst our findings. A previous study, including a subset of our study population, showed that
the highest contribution towards total energy intake at age 10 years came from “refined grains” and
“sugar-sweetened foods” [30], which might suggest that the CHO consumed by children in our study
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population consisted largely of refined grains and sugars. Investigation into the effects of replacing
SFA with different quality CHO is beyond the scope of the present study, but should be considered for
further research in this age group.
Comparison of our results with existing evidence in adolescents is restricted due to the absence of
studies carried out during this life period. One similar study observed theoretical effects of substituting
MUFA or PUFA for SFA, and total fat for CHO from ages 8 to 11 years [25]. The study findings
included slightly lowered total cholesterol when replacing SFA with MUFA or PUFA and higher HDL
when replacing CHO with fat. Based on these findings, the authors suggested a similar effect of
diet on serum lipids to that observed in adults [25]. Unfortunately, LDL, TAG and TOTAL:HDL
were not included among the serum lipid measurements and so comparison with our study is
limited. Nevertheless, our findings also seem to be to some extent comparable to observations
in adult populations. Our results further suggest a sex-specific role of SFA (when replaced by CHO),
acting mainly in female adolescents. The reasons for this gender discrepancy are unknown but we
speculate that it could be related to possible sex differences in dietary patterns, hormones or pubertal
stage. A greater proportion of girls in our study had entered pubertal onset at age 10 years (Table 1).
It has been shown that physiological insulin resistance occurs during puberty [47], which may explain
why females in the present study were more vulnerable than boys to the potentially adverse effects of
carbohydrates. Additionally, girls in our study had slightly higher CHO intakes, which persisted at a
high level, whilst they decreased in boys.
4.3. Strengths and Limitations
One of the main strengths of this study is its focus on the prospective role of dietary fatty acids on
blood lipids during adolescence, a life period not often addressed and becoming increasingly relevant
in terms of later disease development. Furthermore, we consider isocaloric replacements of SFA, which
can contribute toward better understanding its independent role in the context of other nutrients.
For our analyses, we benefited from a large homogenous population of females and males, providing
data covering a five-year period from childhood to adolescence. The longitudinal nature of this study
is a key aspect which allows us to add to the limited knowledge regarding fatty acid intake and
prospective changes in markers of cardiometabolic risk during adolescence. Given the observational
nature of the study, causality cannot be implied; nevertheless, the prospective analysis offers a temporal
component which provides stronger grounds for a causal interpretation. Whether the observed effect
sizes in this study can be considered clinically relevant might be a point for discussion. Furthermore,
considering that children in the present study are not a high risk population and present normal
blood lipid levels, the observation of associations at this stage provide only an indication of a possible
early role of dietary nutrients in the long-term development of CVD risk factors. Nevertheless, given
the increasing evidence for the progression of risk factors from childhood to adulthood, preventive
measures might already consider this age group. Our findings provide a relevant indication of possible
dietary targets which could support the development of recommendations for early disease prevention.
A main drawback in nutritional epidemiology is the high intercorrelation amongst different
nutrients, which, if overlooked, can lead to incorrect conclusions. The use of substitution models
can provide additional insight through the adjustment for other nutrients. However, the method can
result in multicollinearity within statistical models, again generating misleading associations [32].
In our analyses, we tackle this problem by residualizing highly correlated variables, allowing the
new variable to be included in the same model as the previously correlated nutrient, while avoiding
multicollinearity [33]. A further limitation in the present study was non-random loss-to-follow-up,
which meant that, for example, children of lower social classes might be underrepresented in our
analyses. Therefore the generalizability of our findings is limited, as these cannot be considered
representative of the study area (Table S1). Finally, we are aware of problems associated with
misreporting of dietary intake with the use of FFQs. However, the FFQ was validated to estimate fatty
acids and antioxidants in school-aged children. We observed plausible values in terms of energy intake
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and believe that any misreporting was likely detected through extensive quality control, which was
done at the expense of reducing the sample size, but with no substantial loss of power.
5. Conclusions
In conclusion, our findings suggest that higher SFA intakes might lead to reductions in TAG
concentrations during adolescence. We highlight that observed associations in this context are not
independent of other correlated nutrients. Furthermore, replacement of SFA with CHO in female
children is associated with increasing levels of LDL, TAG and TOTAL:HDL during adolescence.
Our findings confirm observations in adult populations, where detrimental aspects of increased
consumption of CHO at the expense of SFA have been reported. Sex-specific determinants may
however play a greater role during adolescence. It is important that recommendations to reduce SFA
intakes do not overlook the possible effects of other nutrients consumed in their place.
Supplementary Materials: The following are available online at http://www.mdpi.com/2072-6643/9/2/127/s1.
Table S1. Comparison of descriptive characteristics of participants included in analyses (data for exposure at age
10 years and outcome at age 10 years and age 15 years) and participants lost to follow-up (data only for exposure
and outcome at age 10 years).
Acknowledgments: The authors thank all the families for their participation in the GINIplus and LISAplus
studies. Furthermore, we thank all members of the GINIplus and LISAplus Study Groups for their excellent
work. The GINIplus Study Group consists of the following: Institute of Epidemiology I, Helmholtz Zentrum
München, German Research Center for Environmental Health, Neuherberg (Heinrich J, Brüske I, Schulz H,
Flexeder C, Zeller C, Standl M, Schnappinger M, Sußmann M, Thiering E, Tiesler C); Department of Pediatrics,
Marien-Hospital, Wesel (Berdel D, von Berg A); Ludwig-Maximilians-University of Munich, Dr von Hauner
Children’s Hospital (Koletzko S); Child and Adolescent Medicine, University Hospital rechts der Isar of the
Technical University Munich (Bauer CP, Hoffmann U); IUF-Environmental Health Research Institute, Düsseldorf
(Hoffmann B, Link E, Klümper C). The GINIplus study was mainly supported for the first three years of the Federal
Ministry for Education, Science, Research and Technology (interventional arm) and Helmholtz Zentrum Munich
(former GSF) (observational arm). The 4 year, 6 year, 10 year and 15 year follow-up examinations of the GINIplus
study were covered from the respective budgets of the five study centers (Helmholtz Zentrum Munich (former
GSF), Research Institute at Marien-Hospital Wesel, LMU Munich, TU Munich and from 6 years onwards also from
IUF—Leibniz Research-Institute for Environmental Medicine at the University of Düsseldorf) and a grant from
the Federal Ministry for Environment (IUF Düsseldorf, FKZ 20462296). The LISAplus Study Group consists of
the following: Helmholtz Zentrum München, German Research Center for Environmental Health, Institute of
Epidemiology I, Munich (Heinrich J, Schnappinger M, Brüske I, Sußmann M, Lohr W, Schulz H, Zeller C, Standl M);
Department of Pediatrics, Municipal Hospital “St. Georg”, Leipzig (Borte M, Gnodtke E); Marien Hospital Wesel,
Department of Pediatrics, Wesel (von Berg A, Berdel D, Stiers G, Maas B); Pediatric Practice, Bad Honnef (Schaaf B);
Helmholtz Centre of Environmental Research—UFZ, Department of Environmental Immunology/Core Facility
Studies, Leipzig (Lehmann I, Bauer M, Röder S, Schilde M, Nowak M, Herberth G , Müller J, Hain A); Technical
University Munich, Department of Pediatrics, Munich (Hoffmann U, Paschke M, Marra S); Clinical Research
Group Molecular Dermatology, Department of Dermatology and Allergy, Technische Universität München (TUM),
Munich (Ollert M). The LISAplus study was mainly supported by grants from the Federal Ministry for Education,
Science, Research and Technology and in addition from Helmholtz Zentrum Munich (former GSF), Helmholtz
Centre for Environmental Research—UFZ, Leipzig, Research Institute at Marien-Hospital Wesel, Pediatric Practice,
Bad Honnef for the first two years. The 4 year, 6 year, 10 year and 15 year follow-up examinations of the LISAplus
study were covered from the respective budgets of the involved partners (Helmholtz Zentrum Munich (former
GSF), Helmholtz Centre for Environmental Research—UFZ, Leipzig, Research Institute at Marien-Hospital Wesel,
Pediatric Practice, Bad Honnef, IUF—Leibniz-Research Institute for Environmental Medicine at the University
of Düsseldorf) and in addition by a grant from the Federal Ministry for Environment (IUF Düsseldorf, FKZ
20462296). Further, the 15 years follow-up examination of the GINIplus and LISAplus studies was supported
by the Commission of the European Communities, the 7th Framework Program: MeDALL project. The 15 year
follow-up examination of the GINIplus study was additionally supported by the Mead Johnson and Nestlé
companies. The work of BK is financially supported in part by the European Research Council Advanced Grant
META-GROWTH (ERC-2012-AdG—no. 322605).
Author Contributions: Marie Standl, Joachim Heinrich, Carla Harris and Anette Buyken were involved in the
conception and design of the study; Sibylle Koletzko, Andrea von Berg, Dietrich Berdel, Tamara Schikowski,
Joachim Heinrich and Marie Standl in the data acquisition; Carla Harris and Marie Standl in the statistical analyses;
Carla Harris, Marie Standl, Anette Buyken, Berthold Koletzko and Joachim Heinrich in the interpretation;
Carla Harris drafted the manuscript; all authors revised it critically for important intellectual content, and
approved the final version to be published.
Conflicts of Interest: The authors declare no conflict of interest.
Nutrients 2017, 9, 127 12 of 14
References
1. Kannel, W.B.; Dawber, T.R.; Kagan, A.; Revotskie, N.; Stokes, J., 3rd. Factors of risk in the development of
coronary heart disease—Six year follow-up experience. The framingham study. Ann. Intern. Med. 1961, 55,
33–50. [CrossRef]
2. Keys, A.; Anderson, J.T.; Grande, F. Serum cholesterol response to changes in the diet: Iv. Particular saturated
fatty acids in the diet. Metab. Clin. Exp. 1965, 14, 776–787. [CrossRef]
3. World Health Organization. Diet, Nutrition and the Prevention of Chronic Diseases; World Health Organization
Technical Report Series; World Health Organization: Geneva, Switzerland, 2003; Volume 916, pp. 1–149.
4. Siri-Tarino, P.W.; Sun, Q.; Hu, F.B.; Krauss, R.M. Meta-analysis of prospective cohort studies evaluating the
association of saturated fat with cardiovascular disease. Am. J. Clin. Nutr. 2010, 91, 535–546. [CrossRef]
[PubMed]
5. Mente, A.; de Koning, L.; Shannon, H.S.; Anand, S.S. A systematic review of the evidence supporting a causal
link between dietary factors and coronary heart disease. Arch. Intern. Med. 2009, 169, 659–669. [CrossRef]
[PubMed]
6. Chowdhury, R.; Warnakula, S.; Kunutsor, S.; Crowe, F.; Ward, H.A.; Johnson, L.; Franco, O.H.;
Butterworth, A.S.; Forouhi, N.G.; Thompson, S.G.; et al. Association of dietary, circulating, and supplement
fatty acids with coronary risk: A systematic review and meta-analysis. Ann. Intern. Med. 2014, 160, 398–406.
[CrossRef] [PubMed]
7. Hodson, L.; Skeaff, C.M.; Chisholm, W.A. The effect of replacing dietary saturated fat with polyunsaturated
or monounsaturated fat on plasma lipids in free-living young adults. Eur. J. Clin. Nutr. 2001, 55, 908–915.
[CrossRef] [PubMed]
8. Mensink, R.P.; Zock, P.L.; Kester, A.D.; Katan, M.B. Effects of dietary fatty acids and carbohydrates on
the ratio of serum total to hdl cholesterol and on serum lipids and apolipoproteins: A meta-analysis of
60 controlled trials. Am. J. Clin. Nutr. 2003, 77, 1146–1155. [PubMed]
9. Food and Agriculture Organization. Fats and Fatty Acids in human Nutrition; Report of an Expert Consultation;
FAO Food and Nutrition Paper; Food and Agriculture Organization: Rome, Italy, 2010; Volume 91, pp. 1–166.
10. WHO Expert Committee on Prevention in Childhood; Youth of Adult Cardiovascular Diseases World Health
Organization. Prevention in Childhood and Youth of Adult Cardiovascular Diseases: Time for Action/Report of a
Who Expert Committee; World Health Organization: Geneva, Switzerland, 1990.
11. Juhola, J.; Magnussen, C.G.; Viikari, J.S.; Kahonen, M.; Hutri-Kahonen, N.; Jula, A.; Lehtimaki, T.;
Akerblom, H.K.; Pietikainen, M.; Laitinen, T.; et al. Tracking of serum lipid levels, blood pressure, and body
mass index from childhood to adulthood: The cardiovascular risk in young finns study. J. Pediatr. 2011, 159,
584–590. [CrossRef] [PubMed]
12. Nicklas, T.A.; von Duvillard, S.P.; Berenson, G.S. Tracking of serum lipids and lipoproteins from childhood to
dyslipidemia in adults: The bogalusa heart study. Int. J. Sports Med. 2002, 23 (Suppl. 1), S39–S43. [CrossRef]
[PubMed]
13. Webber, L.S.; Srinivasan, S.R.; Wattigney, W.A.; Berenson, G.S. Tracking of serum lipids and lipoproteins
from childhood to adulthood. The bogalusa heart study. Am. J. Epidemiol. 1991, 133, 884–899. [PubMed]
14. Meredith, C.N.; Dwyer, J.T. Nutrition and exercise: Effects on adolescent health. Annu. Rev. Public Health
1991, 12, 309–333. [CrossRef] [PubMed]
15. Rogol, A.D.; Roemmich, J.N.; Clark, P.A. Growth at puberty. J. Adolesc. Health 2002, 31, 192–200. [CrossRef]
16. Praagman, J.; de Jonge, E.A.; Kiefte-de Jong, J.C.; Beulens, J.W.; Sluijs, I.; Schoufour, J.D.; Hofman, A.;
van der Schouw, Y.T.; Franco, O.H. Dietary saturated fatty acids and coronary heart disease risk in a dutch
middle-aged and elderly population. Arterioscler. Thromb. Vasc. Biol. 2016, 36, 2011–2018. [CrossRef]
[PubMed]
17. Li, Y.; Hruby, A.; Bernstein, A.M.; Ley, S.H.; Wang, D.D.; Chiuve, S.E.; Sampson, L.; Rexrode, K.M.; Rimm, E.B.;
Willett, W.C.; et al. Saturated fats compared with unsaturated fats and sources of carbohydrates in relation
to risk of coronary heart disease: A prospective cohort study. J. Am. Coll. Cardiol. 2015, 66, 1538–1548.
[CrossRef] [PubMed]
18. Jakobsen, M.U.; O'Reilly, E.J.; Heitmann, B.L.; Pereira, M.A.; Balter, K.; Fraser, G.E.; Goldbourt, U.;
Hallmans, G.; Knekt, P.; Liu, S.; et al. Major types of dietary fat and risk of coronary heart disease: A pooled
analysis of 11 cohort studies. Am. J. Clin. Nutr. 2009, 89, 1425–1432. [CrossRef] [PubMed]
Nutrients 2017, 9, 127 13 of 14
19. Lambert, J.; Agostoni, C.; Elmadfa, I.; Hulshof, K.; Krause, E.; Livingstone, B.; Socha, P.; Pannemans, D.;
Samartin, S. Dietary intake and nutritional status of children and adolescents in europe. Br. J. Nutr. 2004, 92
(Suppl. 2), S147–S211. [CrossRef] [PubMed]
20. Luepker, R.V.; Perry, C.L.; McKinlay, S.M.; Nader, P.R.; Parcel, G.S.; Stone, E.J.; Webber, L.S.; Elder, J.P.;
Feldman, H.A.; Johnson, C.C.; et al. Outcomes of a field trial to improve children’s dietary patterns and
physical activity. The child and adolescent trial for cardiovascular health. Catch collaborative group. J. Am.
Med. Assoc. 1996, 275, 768–776. [CrossRef]
21. Cheng, H.H.; Wen, Y.Y.; Chen, C. Serum fatty acid composition in primary school children is associated with
serum cholesterol levels and dietary fat intake. Eur. J. Clin. Nutr. 2003, 57, 1613–1620. [CrossRef] [PubMed]
22. Bel-Serrat, S.; Mouratidou, T.; Huybrechts, I.; Labayen, I.; Cuenca-Garcia, M.; Palacios, G.; Breidenassel, C.;
Molnar, D.; Roccaldo, R.; Widhalm, K.; et al. Associations between macronutrient intake and serum
lipid profile depend on body fat in european adolescents: The healthy lifestyle in europe by nutrition in
adolescence (helena) study. Br. J. Nutr. 2014, 112, 2049–2059. [CrossRef] [PubMed]
23. Niinikoski, H.; Pahkala, K.; Ala-Korpela, M.; Viikari, J.; Rönnemaa, T.; Lagström, H.; Jokinen, E.; Jula, A.;
Savolainen, M.J.; Simell, O.; et al. Effect of repeated dietary counseling on serum lipoproteins from infancy
to adulthood. Pediatrics 2012, 129, e704–e713. [CrossRef] [PubMed]
24. Ku, C.Y.; Gower, B.A.; Nagy, T.R.; Goran, M.I. Relationships between dietary fat, body fat, and serum lipid
profile in prepubertal children. Obes. Res. 1998, 6, 400–407. [CrossRef] [PubMed]
25. Nicklas, T.A.; Dwyer, J.; Feldman, H.A.; Luepker, R.V.; Kelder, S.H.; Nader, P.R. Serum cholesterol levels
in children are associated with dietary fat and fatty acid intake. J. Am. Diet. Assoc. 2002, 102, 511–517.
[CrossRef]
26. von Berg, A.; Kramer, U.; Link, E.; Bollrath, C.; Heinrich, J.; Brockow, I.; Koletzko, S.; Grubl, A.;
Filipiak-Pittroff, B.; Wichmann, H.E.; et al. Impact of early feeding on childhood eczema: Development after
nutritional intervention compared with the natural course—The giniplus study up to the age of 6 years.
Clin. Exp. Allergy 2010, 40, 627–636.
27. Heinrich, J.; Bolte, G.; Holscher, B.; Douwes, J.; Lehmann, I.; Fahlbusch, B.; Bischof, W.; Weiss, M.; Borte, M.;
Wichmann, H.E. Allergens and endotoxin on mothers’ mattresses and total immunoglobulin E in cord blood
of neonates. Eur. Respir. J. 2002, 20, 617–623. [CrossRef] [PubMed]
28. Stiegler, P.; Sausenthaler, S.; Buyken, A.E.; Rzehak, P.; Czech, D.; Linseisen, J.; Kroke, A.; Gedrich, K.;
Robertson, C.; Heinrich, J. A new FFQ designed to measure the intake of fatty acids and antioxidants in
children. Public Health Nutr. 2010, 13, 38–46. [CrossRef] [PubMed]
29. Willett, W. Nutritional Epidemiology; Oxford University Press: Oxford, UK, 1998.
30. Harris, C.; Flexeder, C.; Thiering, E.; Buyken, A.; Berdel, D.; Koletzko, S.; Bauer, C.P.; Bruske, I.; Koletzko, B.;
Standl, M. Changes in dietary intake during puberty and their determinants: Results from the giniplus birth
cohort study. BMC Public Health 2015, 15, 841. [CrossRef] [PubMed]
31. Hartmann, B.M.; Bell, S.; Vásquez-Caicedo, A.L.; Götz, A.; Erhardt, J.; Brombach, C. Der Bundeslebensmittelschlüssel.
German Nutrient Database; Federal Research Centre for Nutrition and Food (BfEL): Karlsruhe, Germany, 2005.
32. Reed, D.; McGee, D.; Yano, K.; Hankin, J. Diet, blood pressure, and multicollinearity. Hypertension 1985, 7,
405–410. [PubMed]
33. Dormann, C.F.; Elith, J.; Bacher, S.; Buchmann, C.; Carl, G.; Carré, G.; Marquéz, J.R.G.; Gruber, B.;
Lafourcade, B.; Leitão, P.J.; et al. Collinearity: A review of methods to deal with it and a simulation
study evaluating their performance. Ecography 2013, 36, 27–46. [CrossRef]
34. R Core Team. R: A Language and Environment for Statistical Computing; R Foundation for Statistical Computing:
Vienna, Austria, 2016.
35. Wolfram, G.; Bechthold, A.; Boeing, H.; Ellinger, S.; Hauner, H.; Kroke, A.; Leschik-Bonnet, E.; Linseisen, J.;
Lorkowski, S.; Schulze, M.; et al. Evidence-based guideline of the german nutrition society: Fat intake and
prevention of selected nutrition-related diseases. Ann. Nutr. Metab. 2015, 67, 141–204. [CrossRef] [PubMed]
36. Guillaume, M.; Lapidus, L.; Lambert, A. Differences in associations of familial and nutritional factors with
serum lipids between boys and girls: The luxembourg child study. Am. J. Clin. Nutr. 2000, 72, 384–388.
[PubMed]
37. Samuelson, G.; Bratteby, L.E.; Mohsen, R.; Vessby, B. Dietary fat intake in healthy adolescents: Inverse
relationships between the estimated intake of saturated fatty acids and serum cholesterol. Br. J. Nutr. 2001,
85, 333–341. [CrossRef] [PubMed]
Nutrients 2017, 9, 127 14 of 14
38. Altwaijri, Y.A.; Day, R.S.; Harrist, R.B.; Dwyer, J.T.; Ausman, L.M.; Labarthe, D.R. Sexual maturation affects
diet–blood total cholesterol association in children: Project heartbeat! Am. J. Prev. Med. 2009, 37, S65–S70.
[CrossRef] [PubMed]
39. Siri-Tarino, P.W.; Chiu, S.; Bergeron, N.; Krauss, R.M. Saturated fats versus polyunsaturated fats versus
carbohydrates for cardiovascular disease prevention and treatment. Ann. Rev. Nutr. 2015, 35, 517–543.
[CrossRef] [PubMed]
40. Parks, E.J.; Hellerstein, M.K. Carbohydrate-induced hypertriacylglycerolemia: Historical perspective and
review of biological mechanisms. Am. J. Clin. Nutr. 2000, 71, 412–433. [PubMed]
41. Siri-Tarino, P.W.; Sun, Q.; Hu, F.B.; Krauss, R.M. Saturated fat, carbohydrate, and cardiovascular disease.
Am. J. Clin. Nutr. 2010, 91, 502–509. [CrossRef] [PubMed]
42. Panel on Dietetic Products, Nutrition and Allergies. Scientific opinion on dietary reference values for fats,
including saturated fatty acids, polyunsaturated fatty acids, monounsaturated fatty acids, trans fatty acids,
and cholesterol. EFSA J. 2010, 8. [CrossRef]
43. Mensink, R.P.; Katan, M.B. Effect of dietary fatty acids on serum lipids and lipoproteins. A meta-analysis of
27 trials. Arterioscler. Thromb. 1992, 12, 911–919. [CrossRef] [PubMed]
44. Sacks, F.M.; Katan, M. Randomized clinical trials on the effects of dietary fat and carbohydrate on plasma
lipoproteins and cardiovascular disease. Am. J. Med. 2002, 113 (Suppl. 9B), 13S–24S. [CrossRef]
45. Krauss, R.M.; Blanche, P.J.; Rawlings, R.S.; Fernstrom, H.S.; Williams, P.T. Separate effects of reduced
carbohydrate intake and weight loss on atherogenic dyslipidemia. Am. J. Clin. Nutr. 2006, 83, 1025–1031.
[PubMed]
46. Te Morenga, L.A.; Howatson, A.J.; Jones, R.M.; Mann, J. Dietary sugars and cardiometabolic risk: Systematic
review and meta-analyses of randomized controlled trials of the effects on blood pressure and lipids. Am. J.
Clin. Nutr. 2014, 100, 65–79. [CrossRef] [PubMed]
47. Amiel, S.A.; Sherwin, R.S.; Simonson, D.C.; Lauritano, A.A.; Tamborlane, W.V. Impaired insulin action in
puberty. N. Engl. J. Med. 1986, 315, 215–219. [CrossRef] [PubMed]
© 2017 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
